{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T02:21:37Z","timestamp":1782181297492,"version":"3.54.5"},"reference-count":17,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.annder.2018.07.010","type":"journal-article","created":{"date-parts":[[2018,9,7]],"date-time":"2018-09-07T03:38:25Z","timestamp":1536291505000},"page":"761-764","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["N\u00e9croses digitales r\u00e9v\u00e9lant une maladie des agglutinines froides\u00a0: traitement par rituximab"],"prefix":"10.1016","volume":"145","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1645-9281","authenticated-orcid":false,"given":"T.","family":"Klejtman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Garel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Senet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Tribout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Bachmeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Barbaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4792-2622","authenticated-orcid":false,"given":"J.-B.","family":"Monfort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.annder.2018.07.010_bib0090","doi-asserted-by":"crossref","first-page":"445s","DOI":"10.1016\/S0248-8663(01)80057-6","article-title":"N\u00e9croses et isch\u00e9mies digitales du membre sup\u00e9rieur\u00a0: \u00e9tude r\u00e9trospective de 278\u00a0observations","volume":"22","author":"Delcey","year":"2001","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.annder.2018.07.010_bib0095","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.annder.2015.02.018","article-title":"Isch\u00e9mie digitale aigu\u00eb\u00a0: \u00e9tude r\u00e9trospective de 13\u00a0cas","volume":"142","author":"Marchal","year":"2015","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.annder.2018.07.010_bib0100","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1097\/MD.0000000000000047","article-title":"Digital ischemia associated with cancer: results from a cohort study","volume":"93","author":"Le Besnerais","year":"2014","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.annder.2018.07.010_bib0105","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.autrev.2013.11.010","article-title":"Diagnosis and classification of autoimmune hemolytic anemia","volume":"13","author":"Bass","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.annder.2018.07.010_bib0110","first-page":"405","article-title":"Activation of complement by cold agglutinins","volume":"21","author":"Kirschfink","year":"1994","journal-title":"Infusionsther Transfusionsmed"},{"key":"10.1016\/j.annder.2018.07.010_bib0115","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.blre.2012.01.002","article-title":"Diagnosis and treatment of cold agglutinin mediated autoimmune hemolytic anemia","volume":"26","author":"Berentsen","year":"2012","journal-title":"Blood Rev"},{"key":"10.1016\/j.annder.2018.07.010_bib0120","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1182\/blood-2013-02-474437","article-title":"Cold agglutinin disease","volume":"122","author":"Swiecicki","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.annder.2018.07.010_bib0125","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.revmed.2004.08.001","article-title":"Cold agglutinins, clinical presentation and significance: retrospective analysis of 58\u00a0patients","volume":"25","author":"Chandesris","year":"2004","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.annder.2018.07.010_bib0130","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.hoc.2015.01.002","article-title":"Cold agglutinin-mediated autoimmune hemolytic anemia","volume":"29","author":"Berentsen","year":"2015","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.annder.2018.07.010_bib0135","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/ajh.2830350415","article-title":"A fatal case of low titer anti-PR cold agglutinin disease","volume":"35","author":"Rousey","year":"1990","journal-title":"Am J Hematol"},{"key":"10.1016\/j.annder.2018.07.010_bib0140","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/j.1365-2141.2007.06664.x","article-title":"Management of cold haemolytic syndrome","volume":"138","author":"Gertz","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.annder.2018.07.010_bib0145","doi-asserted-by":"crossref","first-page":"575","DOI":"10.4103\/0378-6323.144221","article-title":"Cold agglutinin disease-associated digital gangrene treated with plasmapheresis","volume":"80","author":"Koike","year":"2014","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.annder.2018.07.010_bib0150","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1034\/j.1600-0609.2000.9l201.x","article-title":"No response to cladribine in five patients with chronic cold agglutinin disease","volume":"65","author":"Berentsen","year":"2000","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.annder.2018.07.010_bib0155","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0248-8663(03)00139-5","article-title":"Int\u00e9r\u00eat du rituximab dans la maladie des agglutinines froides","volume":"24","author":"Camou","year":"2003","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.annder.2018.07.010_bib0160","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/10428190500286481","article-title":"Rituximab in chronic cold agglutinin disease: a prospective study of 20\u00a0patients","volume":"47","author":"Sch\u00f6llkopf","year":"2006","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.annder.2018.07.010_bib0165","doi-asserted-by":"crossref","first-page":"3180","DOI":"10.1182\/blood-2010-06-288647","article-title":"High response rate and durable remissions following fludarabine and rituximab combination therapy for chronic cold agglutinin disease","volume":"116","author":"Berentsen","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.annder.2018.07.010_bib0085","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3892\/ol.2013.1695","article-title":"Primary bone marrow diffuse large B-cell lymphoma accompanying cold agglutinin disease: a case report with review of the literature","volume":"7","author":"Yamashita","year":"2014","journal-title":"Oncol Lett"}],"container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963818305003?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963818305003?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T11:06:34Z","timestamp":1758971194000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0151963818305003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":17,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S0151963818305003"],"URL":"https:\/\/doi.org\/10.1016\/j.annder.2018.07.010","relation":{},"ISSN":["0151-9638"],"issn-type":[{"value":"0151-9638","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"N\u00e9croses digitales r\u00e9v\u00e9lant une maladie des agglutinines froides\u00a0: traitement par rituximab","name":"articletitle","label":"Article Title"},{"value":"Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annder.2018.07.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}